Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

It is estimated that in 2024, after deducting non-recurring items, the loss will be reduced by more than 30%. Special Treat Bubugao plans to complete the supermarket store adjustments before August this year | Interpretations

① Special Treat Bubugao expects to achieve a net income of 0.86 billion to 1.26 billion yuan in 2024, turning losses into profits year-on-year; after deducting non-recurring items, the net income is expected to be -0.76 billion to -1.12 billion yuan, which is a reduction in loss of 31.35% to 53.42% year-on-year. ② Special Treat Bubugao plans to complete the adjustment of supermarket stores by August this year and aims to launch its own brand commodity in Q1.

cls.cnJan 22 10:58 ET

Is the restructuring the peak? Guangzhou Grandbuy's performance continues to decline as Bank of China Investment continuously makes "precise" Shareholding reductions | Quick read announcement.

① In the past 11 trading days, Guangzhou Grandbuy has hit the limit up six times, while China Merchants Investment has continuously and "precisely" reduced its shareholding by nearly 3% since January 3. ② After achieving peak performance through asset restructuring in 2021, Guangzhou Grandbuy has shown poor performance in recent years, and the major shareholders' successive reductions may have other considerations.

cls.cnJan 16 10:47 ET

The challenge of store transformation: Yonghui Superstores is expected to continue incurring losses in 2024 | Interpretations

① Yonghui Superstores expects a net income loss of 1.4 billion yuan in 2024. This marks the company's fourth consecutive year of recording a net income loss since 2021; ② In 2024, Yonghui Superstores continues to face pressure on overall foot traffic and average transaction value, and store adjustments require significant investment, compounded by the company closing some underperforming stores, resulting in a decline in last year's performance; ③ Looking ahead to 2025, Yonghui Superstores will continue its store adjustments.

cls.cnJan 14 08:56 ET

Significant increase in net profit! Baida Group Co.,Ltd sold another 0.17 million shares of Bank Of Hangzhou, as strong bank stocks were frequently subject to Shareholding last year.

On the evening of January 2, Baida Group Co., Ltd. (hereinafter referred to as Baida Group) announced that in December last year, the company sold 170,000 shares of Bank of Hangzhou, with a transaction amount of approximately 2.42 million yuan. Throughout last year, the Shareholding reduction of Bank of Hangzhou stocks cumulatively impacted the Net income attributable to the shareholders of the listed company by 13.9799 million yuan, accounting for 103.01% of the most recent audited Net income attributable to the shareholders of the listed company.

cls.cnJan 2 09:23 ET

Pang Donglai has been elevated to the "altar".

However, apprentices find it difficult to replicate.

wallstreetcnDec 31, 2024 08:50 ET